Literature DB >> 23036671

Chronic medical conditions as risk factors for herpes zoster.

Riduan M Joesoef1, Rafael Harpaz, Jessica Leung, Stephanie R Bialek.   

Abstract

OBJECTIVE: To determine the degree to which chronic conditions might contribute to the unexplained burden of herpes zoster.
METHODS: We conducted a case-control study using MarketScan data from January 1, 2007, through December 31, 2007, to investigate chronic conditions as risk factors for herpes zoster among persons 20 to 64 years old. Cases were enrollees with a herpes zoster diagnosis (International Classification of Diseases, Ninth Revision, Clinical Modification codes 053.xx), and controls were those without a herpes zoster diagnosis, matched by age groups and insurance plan. We selected 10 chronic conditions based on their prevalence in the general population. We calculated the attributable fraction and created a comorbidity composite score by summing the significant coefficient of regression of chronic conditions. We used logistic regression to evaluate the associations between herpes zoster and chronic conditions.
RESULTS: We identified a total of 59,173 cases and 616,177 controls for the analysis. Risk of herpes zoster was significant for 8 of the 10 study conditions (odds ratios, 1.06-1.52). Herpes zoster risk also increased as a function of comorbidity composite score. The attributable fractions for these 8 significant conditions ranged from 0.24% to 2.89%.
CONCLUSION: The risk of herpes zoster may be increased in people with chronic conditions. However, this risk may not contribute substantially to the burden of herpes zoster in the population. The causes for most cases of herpes zoster remain unknown.
Copyright © 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23036671      PMCID: PMC3538398          DOI: 10.1016/j.mayocp.2012.05.021

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  27 in total

Review 1.  Treatment and prevention of postherpetic neuralgia.

Authors:  Robert H Dworkin; Kenneth E Schmader
Journal:  Clin Infect Dis       Date:  2003-03-13       Impact factor: 9.079

2.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

3.  Selective decline in cellular immune response to varicella-zoster in the elderly.

Authors:  A E Miller
Journal:  Neurology       Date:  1980-06       Impact factor: 9.910

4.  Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination.

Authors:  Jessica Leung; Rafael Harpaz; Noelle-Angelique Molinari; Aisha Jumaan; Fangjun Zhou
Journal:  Clin Infect Dis       Date:  2011-02-01       Impact factor: 9.079

Review 5.  Recent advances in varicella-zoster virus infection.

Authors:  J I Cohen; P A Brunell; S E Straus; P R Krause
Journal:  Ann Intern Med       Date:  1999-06-01       Impact factor: 25.391

6.  The incidence of herpes zoster.

Authors:  J G Donahue; P W Choo; J E Manson; R Platt
Journal:  Arch Intern Med       Date:  1995 Aug 7-21

7.  Racial and psychosocial risk factors for herpes zoster in the elderly.

Authors:  K Schmader; L K George; B M Burchett; C F Pieper
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

8.  Cellular immunity to varicella-zoster virus in patients with major depression.

Authors:  M Irwin; C Costlow; H Williams; K H Artin; C Y Chan; D L Stinson; M J Levin; A R Hayward; M N Oxman
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

9.  Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records.

Authors:  Yuka Kiyota; Sebastian Schneeweiss; Robert J Glynn; Carolyn C Cannuscio; Jerry Avorn; Daniel H Solomon
Journal:  Am Heart J       Date:  2004-07       Impact factor: 4.749

10.  The role of stress in the development of herpes zoster and postherpetic neuralgia.

Authors:  J M Livengood
Journal:  Curr Rev Pain       Date:  2000
View more
  31 in total

1.  [Benefits of zoster vaccination in older patients].

Authors:  K Meier; A S Yazdi
Journal:  Hautarzt       Date:  2017-05       Impact factor: 0.751

Review 2.  Prevention of Herpes Zoster and its complications: From clinical evidence to real life experience.

Authors:  Giovanni Gabutti; Paolo Bonanni; Michele Conversano; Guido Fanelli; Elisabetta Franco; Donato Greco; Giancarlo Icardi; Marzia Lazzari; Alessandro Rossi; Silvestro Scotti; Antonio Volpi
Journal:  Hum Vaccin Immunother       Date:  2016-12-07       Impact factor: 3.452

3.  Long-term clinical outcomes of peritoneal dialysis patients: 9-year experience of a single center from north India.

Authors:  Sanjay Vikrant
Journal:  Perit Dial Int       Date:  2014-01-02       Impact factor: 1.756

4.  Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity.

Authors:  Ryu Watanabe; Tsuyoshi Shirai; Hong Namkoong; Hui Zhang; Gerald J Berry; Barbara B Wallis; Benedikt Schaefgen; David G Harrison; Jennifer A Tremmel; John C Giacomini; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Clin Invest       Date:  2017-06-12       Impact factor: 14.808

5.  The temporal impact of aging on the burden of herpes zoster.

Authors:  Lijoy Varghese; Baudouin Standaert; Antonio Olivieri; Desmond Curran
Journal:  BMC Geriatr       Date:  2017-01-23       Impact factor: 3.921

6.  Increased Health Care Resource Utilization and Costs Associated with Herpes Zoster Among Patients Aged ≥50 Years with Chronic Obstructive Pulmonary Disease in the United States.

Authors:  Parinaz Ghaswalla; Philippe Thompson-Leduc; Wendy Y Cheng; Colin Kunzweiler; Min-Jung Wang; Michael Bogart; Brandon J Patterson; Mei Sheng Duh; John Wojciehowski; Suna Park; Barbara P Yawn
Journal:  Chronic Obstr Pulm Dis       Date:  2021-10-28

7.  Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain).

Authors:  María D Esteban-Vasallo; M Felicitas Domínguez-Berjón; Ruth Gil-Prieto; Jenaro Astray-Mochales; Angel Gil de Miguel
Journal:  Hum Vaccin Immunother       Date:  2014-05-07       Impact factor: 3.452

8.  Examination of links between herpes zoster incidence and childhood varicella vaccination.

Authors:  Craig M Hales; Rafael Harpaz; M Riduan Joesoef; Stephanie R Bialek
Journal:  Ann Intern Med       Date:  2013-12-03       Impact factor: 25.391

9.  Burden of Herpes Zoster in Adult Patients with Underlying Conditions: Analysis of German Claims Data, 2007-2018.

Authors:  Manuel Batram; Julian Witte; Magdalena Schwarz; Johannes Hain; Bernhard Ultsch; Maren Steinmann; Amit Bhavsar; Peter Wutzler; Carl-Peter Criée; Christiane Hermann; Klaus Wahle; Martin Füchtenbusch; Wolfgang Greiner
Journal:  Dermatol Ther (Heidelb)       Date:  2021-05-06

10.  Mood Disorders and Risk of Herpes Zoster in 2 Population-Based Case-Control Studies in Denmark and the United Kingdom.

Authors:  Sigrun A J Schmidt; Sinéad M Langan; Henrik S Pedersen; Henrik C Schønheyder; Sara L Thomas; Liam Smeeth; Kathryn E Mansfield; Henrik T Sørensen; Harriet J Forbes; Mogens Vestergaard
Journal:  Am J Epidemiol       Date:  2018-05-01       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.